Affinity optimized EphA2 agonistic antibodies and methods of use thereof
Details for Australian Patent Application No. 2006331775 (hide)
International Classifications
Event Publications
7 August 2008 PCT application entered the National Phase
PCT publication WO2007/075706 Priority application(s): WO2007/075706
2 October 2008 Alteration of Name
The name of the applicant has been altered to MedImmune, LLC
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006331783-Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser